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Abstract
Introduction: Alveolar adenomas are extremely rare, benign, primary lung tumors of unknown histogenesis that
are characterized by proliferative type II alveolar epithelium and septal mesenchyma. Mostly incidental, they are
clinically important as they can imitate benign primary and secondary malignant tumors and at times are difficult
to differentiate from early-stage lung cancer. We describe the case of a 59-year-old man with an incidental
microscopic alveolar adenoma coexisting with poorly differentiated lung carcinoma.
Case presentation: A 59-year-old Caucasian man with a medical history of smoking and chronic obstructive
pulmonary disease was incidentally found to have a right upper lobe mass while undergoing a computed
tomographic chest scan as part of a chronic obstructive pulmonary disease clinical trial. Our patient underwent a
right upper lobectomy after a bronchoscopic biopsy of the mass revealed the mass to be a carcinoma. A
pathological examination revealed an incidental, small, 0.2 cm, well circumscribed lesion on the staple line margin
of the lobectomy in addition to the carcinoma. Histopathological and immunohistochemical examinations revealed
the lesion to be an alveolar adenoma.
Conclusions: We report the rare presentation of a microscopic alveolar adenoma coexisting with lung carcinoma.
Alveolar adenoma is an entirely benign incidental neoplasm that can be precisely diagnosed using
immunohistochemical analysis in addition to its unique histopathological characteristics.
Introduction
Alveolar adenomas (AAs) or ‘Yousem’s tumors’, first
described by Yousem and Hochholzer in 1986 [1], are
pulmonary tumors of uncertain histogenesis. Several
types of pulmonary adenomas are recognized by the
revised World Health Organization/International Asso-
ciation for the Study of Lung Cancer classification [2].
AAs are characterized by proliferation of type II alveolar
epithelium and septal mesenchyma [3]. They are histolo-
gically benign, and recurrence after resection has never
been reported [4-6]. AAs are detected incidentally as
isolated coin lesions on routine chest radiographs [4,7];
however, at times, they are difficult to differentiate from
the early stages of lung cancer. They usually occur in
the middle and lower lobes of middle-aged and older
women [8]. AAs have a characteristic multi-cystic histol-
ogy resembling normal lung parenchyma. They are well
demarcated peripheral pulmonary lesions composed of a
network of spaces lined with simple cuboidal epithelium
that contain stroma ranging from thin, inconspicuous
strands of connective tissue to broad accumulations of
spindle cells accompanied by a myxoid matrix [4]. A
review of the English language medical literature
revealed that fewer than 30 cases of AA have been
reported to date [1,4-6]. We describe the rare case of an
incidental, microscopic (0.2 cm) AA coexisting with
lung carcinoma.
Case presentation
A 59-year-old Caucasian man with a medical history of
smoking and chronic obstructive pulmonary disease
(COPD) who was incidentally found to have a right
upper lobe mass while undergoing computed tomogra-
phy (CT) of the chest as part of a clinical trial for
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COPD. A positron emission tomographic scan demon-
strated fluorodeoxyglucose avidity of a suprahilar right
upper lobe mass without any mediastinal lymphadeno-
pathy. Our patient underwent a bronchoscopic biopsy of
the mass, which revealed it to be a carcinoma, and he
was referred for surgery. Our patient then underwent a
right upper lobectomy and tolerated the procedure well
without any remarkable post-operative course. A patho-
logical examination of the right lung lobe revealed a 5
cm poorly differentiated carcinoma. Immunohistochem-
ical stains of tumor sections revealed a high Ki-67 pro-
liferation index, positive cytokeratin 5/6 (CK 5/6),
focally positive p63 and negative p53 status.
Incidentally, a 0.2 cm circumscribed microscopic
lesion was identified on the stapled parenchymal margin
of the lung lobe. Histologically, this lesion was well
demarcated and composed of bland cuboidal cells and
was morphologically different from the original lung
carcinoma. The interstitial cellular component consisted
of vaguely spindle-shaped cells (Figure 1). Considering
the morphology of the lesion, a panel of differential
diagnoses, including AA, adenomatoid tumor, gloman-
gioma and tumorlet, were entertained. Immunohisto-
chemistry revealed the lesion to stain positively for CK
AE1/AE3 antibody (Figure 2a) and thyroid transcription
factor 1 (TTF-1) (Figure 2b) and negatively for p53,
synaptophysin, chromogranin, p63, S-100, CD31, calre-
tenin and Wilms’ tumor 1 (WT1). The combination of
morphological and immunohistochemical studies con-
firmed the lesion to be a microscopic AA.
Discussion
To the best of our knowledge, the coexistence of a micro-
scopic AA with lung carcinoma has not been reported
previously. Approximately 30 cases of AA, mostly inci-
dental, have been identified in the English language med-
ical literature to date. However, the exact number of
these cases is difficult to ascertain, as these tumors are
easily confused with other rare lung tumors. In 1999,
Burke et al. [4] reported 25 true cases of AAs on the
basis of histology and histochemical and immunohisto-
chemical studies. The average size of AAs reported in the
literature is 4.5 cm (ranging from 1 cm to 9 cm), with the
smallest size described being 8 mm [9].
AAs are clinically important as they can imitate differ-
ent specific lung diseases, focal non-specific inflamma-
tion and benign primary or secondary malignant
tumors. Recognition of its characteristic morphological
appearance allows for its distinction from other benign
lesions of the lung. The indolent clinical progression
and absence of recurrence and metastasis after complete
resection are important characteristics indicative of the
benign nature of AAs that are confirmed by a diploid
DNA pattern visualized by flow cytometry, a low Ki-67
proliferation index and negative immunohistochemical
p53 status [10]. In accordance with these findings, the
benign character of the AA in our patient was evident
on the basis of the immunohistochemical studies show-
ing an absence of Ki-67 and p63 staining that was in
contrast to the malignant character of the primary carci-
noma of the lung diagnosed on the basis of a high Ki-67
proliferation index and a focally positive p63 status. The
distinction of the behavior patterns between the two
tumors on the basis of p53 status, however, was equivo-
cal because neither of the tumors showed positivity on
p53 immunohistochemical staining.
Macroscopically, AAs are well demarcated, spongy
nodules located in any lobe beneath intact pleura. Not
truly encapsulated, their borders are sharply demarcated
from adjacent compressed lung tissue, allowing for sur-
gical enucleation of the lesions. Most of the cases are
asymptomatic [4], and a few of the patients have symp-
toms that are unrelated to the lesion or are pleuritic in
nature. These lesions have unknown growth potential
and are usually stable over a long period of time; only
one case showed 20% growth during an 8-month fol-
low-up period [11].
Small, frozen biopsy sections are usually non-diagnos-
tic for AAs as they closely resemble normal lung par-
enchyma. Occasionally, they might simulate a
malignancy if the small glandular spaces are lined with
regular glandular epithelium [4]. CT investigation is
non-specific and shows a well defined, circumscribed
mass with homogeneous density. A bronchoscopy is
unlikely to reveal AAs, owing to the subpleural location
of these lesions. Accurate diagnosis requires correct
recognition of the lesion’s histological characteristics
that is supported by immunohistochemical studies.
Figure 1 Lesion consisting of irregular shaped spaces lined
with flat cuboidal epithelium with a few spaces containing
eosinophilic granular material. The interstitium contains a myxoid
matrix (hematoxylin and eosin stain; original magnification, 40 ×).
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The histopathology of AAs is variable. Most AAs are
well demarcated, multi-cystic and lined by a single layer
of epithelial cells that are cuboidal or hobnailed in
appearance [3,10]. The interstitial component usually
contains collagen fibrils and spindle-shaped cells resem-
bling fibroblasts or modified smooth muscle cells [3,4].
The cytoplasm is eosinophilic, finely vacuolated or
foamy. Immunohistochemical studies have consistently
shown that the epithelial cells in AAs are positive for
TTF-1, and almost all of them are CK positive.
Although most reports do not specify the subgroup of
CKs tested, antibodies against AE1/AE3, CK1, CK7,
CK18 and CK19 have been found to be positive in these
tumors [3,4]. In accordance with these findings, our case
demonstrated positivity for AE1/AE3 and TTF-1 and
was negative for synaptophysin, chromogranin, S-100,
CD31, calretenin and WT1.
The differential diagnoses of AAs are extensive, and
those that need to be addressed include pulmonary ade-
noma, sclerosing hemangiomas, lymphangioma, atypical
adenomatous hyperplasia and bronchoalveolar carci-
noma [4]. A prominent papillary pattern and a heteroge-
neous epithelial component distinguish AAs from
pulmonary adenomas. Sclerosing hemangiomas may also
form cystic spaces, but they contain blood and not eosi-
nophilic material. The TTF-1 expression observed in
AAs is very important in discriminating AAs from scler-
osing hemangiomas. Lymphangiomas contain lining cells
that are CK negative and endothelial marker positive.
Atypical adenomatous hyperplasias present an atypical
bronchoalveolar proliferation, whereas AAs lack cellular
atypia [4].
AAs are characterized by a proliferative alveolar
epithelium and septal mesenchyma [3]. Microscopic stu-
dies [1,4] and immunohistochemical studies [5] targeted
at apoproteins B and C of human surfactant demon-
strate that the epithelial component is derived from type
II pneumocytes. Some authors, however, have suggested
that the cell of origin in AAs is probably a primitive
mesenchymal cell that has the capacity to differentiate
toward a type II pneumocyte [10,12]. The interstitial
component varies from sparse to exuberant, showing
collagen fibrils and spindle-shaped or oval cells. Immu-
nohistochemical studies and ultrastructural studies
shown in several case reports have verified that the
interstitial cellular component of these tumors is made
up of fibroblasts or fibroblast-like cells [4]. While prolif-
eration of type II pneumocytes is more characteristic of
AAs, mesenchymal proliferation is most likely secondary
in character, being stimulated by the growth of epithelial
cells, and it is seen in central zones of the tumor and as
a residual lesion on its periphery.
Conclusions
AAs usually present as an incidental solitary pulmonary
mass sharing an overlap of radiographic appearance
with bronchial adenomas, papillary adenomas and focal
bronchoalveolar carcinomas. They are entirely benign
neoplasms that can be precisely diagnosed on the basis
of immunohistochemical analysis in addition to its
unique histopathological characteristics. In summary,
this is the first case report in the literature describing
the rare presentation of AA coexisting along with lung
carcinoma in the same lobe of the lung.
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Written informed consent was obtained from the patient
for publication of this case report and any accompany-
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for review by the Editor-in-Chief of this journal.
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Figure 2 Immunohistochemical staining showing positivity for (a) cytokeratin AE1/AE3 antibody (original magnification, 40×) and (b)
thyroid transcription factor 1 (original magnification, 100×) in the epithelial cells lining the cysts.
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